Medical Device Regulatory Compliance

Expert Consultancy for
Biological Safety

Navigating the complex world of medical device compliance with
personalized expertise. Your partner in achieving regulatory
approval.

About Us

Technological advances in the last three decades have provided exponential growth to the medical device industries. Bringing any medical device to the market requires regulatory approvals. With an ever-changing technology – regulations and standards are also constantly evolving. These regulations are made keeping safety of the patient at its core and that is also our goal.

At Eunoia Compliance, we understand the need of our clients. Be it an existing product that needs compliance with new regulation or a new product, we understand that you want accelerated, timely and continuous approval of your products. We believe that every client and every project is unique. Whether, biocompatibility of your product, particle testing or risk management, we provide personalized consultancy services which is tailored to your requirements.

Our Services

Comprehensive Compliance Solutions

We understand that every client and every project is unique. Our services
are tailored to meet your specific regulatory needs.

Biological Safety of Medical Device

Strategic planning, organizing biological and chemical testing to ensure your medical devices meet all safety requirements.

Toxicological Risk Assessment

Gathering physical and chemical information on medical devices, materials or components for comprehensive risk evaluation.

Gap Assessment

Performing gap assessments and planning regulatory strategies to identify compliance requirements and create actionable roadmaps.

Consultancy for Material Safety

Expert guidance on material compliance ensuring your products meet international material safety standards.

Failed Biocompatibility Test

Understanding failure reasons, evaluating and creating technical memorandums for adverse test results.

Particulate Testing of Medical Devices

Support from developing simulated use models to writing protocols and reports for particulate testing requirements.

OUR PROCESS

How We Work With You

A streamlined approach to achieving your regulatory compliance goals

0 0

Initial Consultation

We discuss your product requirements and regulatory needs

0 0

Assessment & Strategy​​

Comprehensive gap analysis and strategic planning

0 0

Implementation​

Execute testing protocols and documentation

0 0

Approval Support​

Guide you through the regulatory approval process

WHY CHOOSE US

Your Trusted Partner in Regulatory Excellence.

At Eunoia Compliance, we understand the need of our clients. With expertise in ever-changing technology and evolving regulations, we provide personalized consultancy services that put patient safety at the core.

0 +

Years of Combined Expertise

Our team brings decades of experience in medical device regulatory compliance, biocompatibility testing, and risk
assessment.

Product Approved
0 +
Global
Clients
0 +

Eunoia Compliance Knowledge Base

Our Clients​

TESTIMONIALS

Trusted by Industry Leaders

Priyanka Murawala, Ph.D., DABT

Founder & Principal Consultant

Dr. Murawala is a biocompatibility and regulatory strategy expert with global experience across research, industry, and medical device compliance. With a PhD in Nanobiotechnology and postdoctoral work in cancer biology and high-throughput screening at leading research institutes in Germany, she brings strong scientific depth to regulatory decision-making.

Frequently Asked Questions

What is the primary goal of biocompatibility testing?

It is a systematic scientific process used to evaluate whether a device’s materials, coatings, or chemical constituents cause harm—such as cytotoxicity or sensitization—when interacting with living tissue.

Not necessarily. The 2025 framework shifts away from prescriptive testing toward scientifically justified, risk-based reasoning. Legacy files authored under the 2018 version may require a structured Gap Assessment to meet current regulatory scrutiny.

No. ISO 10993-17 and 10993-18 emphasize Toxicological Risk Assessment (TRA) and chemical characterization. This approach allows manufacturers to justify waiving certain in vivo tests when chemical evidence demonstrates negligible risk.

We partner with manufacturers to develop Biological Evaluation Plans (BEP) and Reports (BER) that include explicit Tolerable Intake (TI) values and toxicological thresholds required for successful market access.

GET IN TOUCH

Ready to Start Your Compliance Journey?

Contact us today to schedule a consultation. We’re here to help you navigate the regulatory landscape with confidence.

Address

1685, State Highway 102
Bar Harbor, ME 04609-7147, USA

Email

Phone

+1-207-266-1423

Business Hours

Monday – Friday: 8:00 – 18:00 ET